Increasing Knowledge and Interest in Cancer Clinical Trials
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Hematopoietic and Lymphoid Cell Neoplasm
- Sponsor
- Hayley Thompson
- Enrollment
- 384
- Locations
- 1
- Primary Endpoint
- Increase in Clinical Trial Awareness and Knowledge
- Status
- Recruiting
- Last Updated
- 9 months ago
Overview
Brief Summary
This trial investigates how well a video-based clinical trial education session works in increasing knowledge and interest in cancer clinical trials among individuals in the metropolitan Detroit region of the Karmanos Cancer Institute (KCI) catchment area. This educational activity may help researchers learn more about individuals' awareness of clinical trials, knowledge, and intention to participates in a clinical trial.
Detailed Description
PRIMARY OBJECTIVE: I. To increase cancer clinical trial knowledge and interest through video-based education among individuals aged 21 and older in the metropolitan Detroit region of the KCI catchment area. OUTLINE: Participants view educational video consisting of information on the purpose of clinical trials, myths associated with clinical trials, and how to find more information about clinical trials.
Investigators
Hayley Thompson
Hayley Thompson. Ph.D.
Barbara Ann Karmanos Cancer Institute
Eligibility Criteria
Inclusion Criteria
- •Individuals aged 21 and older
- •Participants will be identified through Karmanos Cancer Institute's (KCI) clinical treatment center
- •Participants will be identified through community-based KCI-sponsored events
- •Participants will have voiced an interest to participate followed by an Informed consent
- •Exclusion Criteria
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Increase in Clinical Trial Awareness and Knowledge
Time Frame: Baseline and immediately post intervention up to 1 day
An 11-question true and false questionnaire regarding Knowledge will be administered prior to and immediately after a video-based educational session on Clinical Trials
Secondary Outcomes
- Increase in intentions to participate in cancer clinical trials.(Baseline and immediately post intervention up to 1 day)